@article{9b1e2ace33554fd9a5cce0d963ac7c14,
title = "Response to comment on “Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indications”",
author = "Matthew Krebs and I Bennett",
note = "Funding Information: MGK has participated in advisory boards for Bayer, Roche, Janssen, Octimet, Achilles Therapeutics, and Seattle Genetics; undertaken consultancy for Roche and Janssen; received travel grants from AstraZeneca, BerGenBio, and Immutep; and received research grants from BerGenBio and Roche. IB is an employee of Roche and holds shares in Roche.",
year = "2021",
month = dec,
doi = "10.1016/j.esmoop.2021.100307",
language = "English",
volume = "6",
pages = "100307",
journal = "ESMO Open",
issn = "2059-7029",
publisher = "ESMO Press",
number = "6",
}